跳至主要内容
临床试验/IRCT20230930059556N1
IRCT20230930059556N1已完成3 期

Investigating the effect of Violet syrup as an subsidiary treatment for insomnia in patients with attention deficit hyperactivity disorder treated with Ritalin. In a double-blind clinical trial study in children 6-12 years

Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 12 years(—)
性别
All

入选标准

  • Having DSM 5 diagnostic criteria for ADHD
  • Age 6 to 12 years
  • Not taking any medication affecting the mental state at least 2 weeks before the research

排除标准

  • Mental retardation
  • The presence of any psychiatric disorder except OCD
  • History of allergy to the drugs used in the study
  • Having a serious medical illness such as heart disease
  • Uncontrolled seizure disorder
  • People who have systolic blood pressure above 125 mm Hg or their resting pulse is less than 60 or more than 115 beats per minute.
  • Weight under 5 13 kg

研究者

相似试验